Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: J Med Virol. 2012 Dec 21;85(3):524–529. doi: 10.1002/jmv.23498

Table 2.

Percent Detectability and GMT by Anti-EBV ELISA Serology Test - EBV Serology Reproducibility Study

Assay # Individuals/Specimens Tested % Positivea Overall GMT GMT among Positivesa
EBNA IgA 97/580 48.6% 127.2 287.5
VCAp18 IgA 97/580 58.6% 135.0 225.9
EA ext IgA 97/580 31.2% 84.0 169.9
EAp138 IgA 97/580 18.1% 67.7 154.6
EAd IgA 97/580 17.8% 69.8 195.1
Zebra IgA 97/580 17.4% 65.3 154.3
EA ext IgG 97/580 71.0% 140.0 176.6
EAp138 IgG 97/580 41.6% 94.6 173.1
EAd IgG 97/580 33.6% 82.2 207.0
Zebra IgG 97/580 67.6% 139.3 191.2
a

Statistics are based on specimen not individual-level results